Open Payments

ST BERNARDS MEDICAL CENTER

Type
Teaching hospital
Where
JONESBORO, AR
Medicare CCN
040020
Received
$675,711 in 74 records, 2019 ($4,796 general, $670,915 research)
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2019General payment5$4,796
2019Research payment69$670,915

By company

CompanyRecordsAmountYears
Abbott Laboratories9$296,5842019
Boston Scientific Corporation22$126,7642019
Eli Lilly and Company4$93,8642019
Baxter Healthcare3$82,1802019
Amgen Inc.8$52,8072019
Incyte Corporation6$5,6722019
E.R. Squibb & Sons, L.L.C.1$4,8002019
Celgene Corporation1$3,2352019
Medline Industries LP2$2,4642019
Novartis Pharmaceuticals Corporation1$2,1102019
Pharmacyclics LLC, an AbbVie Company12$1,9002019
Becton, Dickinson and Company1$1,6472019
Ortho-Clinical Diagnostics, Inc.1$9602019
Medical Device Business Services, Inc.1$4502019
Varian Medical Systems, Inc.1$2342019
SEAGEN INC.1$362019

By nature of payment

NatureRecordsAmount
Research payment69$670,915
Gift2$1,881
Compensation for services other than consulting, including serving as faculty or as a speaker at a v1$1,464
Charitable Contribution1$1,000
Space rental or facility fees (teaching hospital only)1$450

Records

DateCompanyAmountNatureFormProductStudyYear
2019-12-25Amgen Inc.$4,000Research paymentCash or cash equivalentNplate Biological, HematologyLCM:A Phase 3 Randomized Placebo Controlled Study of the Treatment of CIT for Solid Tumors- Study 12019
2019-12-24Amgen Inc.$1,500Research paymentCash or cash equivalentNplate Biological, HematologyLCM: A Phase 3 Randomized Placebo Controlled Study of the Treatment of CIT for Solid Tumors- Study 22019
2019-12-24Amgen Inc.$819Research paymentCash or cash equivalentNeulasta Biological, OncologyProspective Observational Study of Onpro vs SOC2019
2019-12-16Boston Scientific Corporation$5,139Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTSAVAL PIVOTAL2019
2019-11-04Boston Scientific Corporation$9,623Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTSAVAL PIVOTAL2019
2019-11-04Boston Scientific Corporation$1,500Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTASAP TOO2019
2019-10-22Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-10-22Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-10-22Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-10-16Incyte Corporation$600Research paymentCash or cash equivalentPROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED 2019
2019-10-16Incyte Corporation$100Research paymentCash or cash equivalentPROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED 2019
2019-10-14Baxter Healthcare$11,895Research paymentCash or cash equivalentRenal - Amia Device, RenalPerformance Evaluation of the AMIA Automated Peritoneal Dialysis -APD- Solution Generation System in Patients Using the 2019
2019-10-08Amgen Inc.$1,500Research paymentIn-kind items and servicesNplate Biological, HematologyLCM: A Phase 3 Randomized Placebo Controlled Study of the Treatment of CIT for Solid Tumors- Study 22019
2019-10-07Boston Scientific Corporation$1,806Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTSAVAL PIVOTAL2019
2019-09-11Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-09-11Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-09-03Boston Scientific Corporation$4,860Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTSAVAL PIVOTAL2019
2019-08-07Amgen Inc.$1,382Research paymentIn-kind items and servicesNeulasta Biological, OncologyProspective Observational Study of Onpro vs SOC2019
2019-07-26Varian Medical Systems, Inc.$234GiftCash or cash equivalent2019
2019-07-15Boston Scientific Corporation$3,915Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTSAVAL PIVOTAL2019
2019-07-10Amgen Inc.$120Research paymentIn-kind items and servicesNplate Biological, HematologyLCM:A Phase 3 Randomized Placebo Controlled Study of the Treatment of CIT for Solid Tumors- Study 12019
2019-07-08Baxter Healthcare$63,785Research paymentCash or cash equivalentRenal - Amia Device, RenalPerformance Evaluation of the AMIA Automated Peritoneal Dialysis -APD- Solution Generation System in Patients Using the 2019
2019-07-03Amgen Inc.$555Research paymentIn-kind items and servicesNplate Biological, HematologyLCM:A Phase 3 Randomized Placebo Controlled Study of the Treatment of CIT for Solid Tumors- Study 12019
2019-06-21Pharmacyclics LLC, an AbbVie Company$250Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-06-21Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-06-17Eli Lilly and Company$443Research paymentIn-kind items and servicesA STUDY OF ABIRATERONE ACETATE PLUS PREDNISONE WITH OR WITHOUT ABEMACICLIB (LY2835219) IN PARTICIPANTS WITH PROSTATE CAN2019
2019-06-14Boston Scientific Corporation$16,323Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTSAVAL PIVOTAL2019
2019-06-10Incyte Corporation$26Research paymentCash or cash equivalentPROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED 2019
2019-06-07Baxter Healthcare$6,500Research paymentCash or cash equivalentRenal - Amia Device, RenalPerformance Evaluation of the AMIA Automated Peritoneal Dialysis -APD- Solution Generation System in Patients Using the 2019
2019-05-22Medline Industries LP$1,000Charitable ContributionCash or cash equivalent2019
2019-05-20Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-05-08Abbott Laboratories$69,819Research paymentCash or cash equivalentTactiCath SE Device, Cardiac Arrhythmias and Heart FailureSafety and Effectiveness of TactiCath Contact Force, Sensor Enabled (TactiCath SE) Catheter for Ablation of Drug Refract2019
2019-05-06Boston Scientific Corporation$16,940Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTPINNACLE FLX2019
2019-05-06Boston Scientific Corporation$5,218Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTPINNACLE FLX2019
2019-04-29Incyte Corporation$100Research paymentCash or cash equivalentPROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED 2019
2019-04-25Novartis Pharmaceuticals Corporation$2,110Research paymentCash or cash equivalentVOTRIENT Drug, ONCOLOGYA RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED PHASE III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PAZOPANIB AS ADJUVAN2019
2019-04-24Abbott Laboratories$54,553Research paymentCash or cash equivalentAMPLATZER Amulet Left Atrial Appendage Occlude Device, Cardiac Arrhythmias and Heart FailureAMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial2019
2019-04-24Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-04-24Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-04-24Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-04-22Boston Scientific Corporation$4,371Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTSAVAL PIVOTAL2019
2019-04-17Abbott Laboratories$14,982Research paymentCash or cash equivalentAMPLATZER Amulet Left Atrial Appendage Occlude Device, Cardiac Arrhythmias and Heart FailureAMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial2019
2019-04-13Medical Device Business Services, Inc.$450Space rental or facility fees (teaching hospital only)Cash or cash equivalentECHELON FLEX Stapler Device, Endo-Mechanical2019
2019-04-11Abbott Laboratories$5,000Research paymentCash or cash equivalentTactiCath SE Device, Cardiac Arrhythmias and Heart FailureSafety and Effectiveness of TactiCath Contact Force, Sensor Enabled (TactiCath SE) Catheter for Ablation of Drug Refract2019
2019-03-26Becton, Dickinson and Company$1,647GiftIn-kind items and services2019
2019-03-20Abbott Laboratories$14,982Research paymentCash or cash equivalentAMPLATZER Amulet Left Atrial Appendage Occlude Device, Cardiac Arrhythmias and Heart FailureAMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial2019
2019-03-18Boston Scientific Corporation$4,403Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTSAVAL PIVOTAL2019
2019-03-14Incyte Corporation$400Research paymentCash or cash equivalentPROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED 2019
2019-03-08Boston Scientific Corporation$370Research paymentIn-kind items and servicesCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTSAVAL PIVOTAL2019
2019-02-27Ortho-Clinical Diagnostics, Inc.$960Research paymentCash or cash equivalentClinical Chemistry Device, DiagnosticsVITROS XT 3400 System VITROS XT 7600 Integrated System Customer Acceptance Testing Plan - SBHS2019
2019-02-26Amgen Inc.$42,930Research paymentCash or cash equivalentNeulasta Biological, OncologyProspective Observational Study of Onpro vs SOC2019
2019-02-25Medline Industries LP$1,464Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentReprocessed Instruments Medical Supply, Reprocessing2019
2019-02-20Abbott Laboratories$59,930Research paymentCash or cash equivalentAMPLATZER Amulet Left Atrial Appendage Occlude Device, Cardiac Arrhythmias and Heart FailureAMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial2019
2019-02-19Boston Scientific Corporation$10,784Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTSAVAL PIVOTAL2019
2019-02-19Boston Scientific Corporation$7,694Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTASAP TOO2019
2019-02-19Boston Scientific Corporation$420Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTPINNACLE FLX2019
2019-02-15Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-02-12SEAGEN INC.$36Research paymentCash or cash equivalentAn Open Label Phase 2 Study of Denintuzumab Mafodotin SGN-CD19A in Combination With RCHOP Rituximab, Cyclophosphamide, D2019
2019-02-05Eli Lilly and Company$62,960Research paymentCash or cash equivalentA RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF ABEMACICLIB COMBINED WITH STANDARD ADJUVANT ENDOCRINE THERAPY VERSUS STANDARD2019
2019-02-05Incyte Corporation$4,446Research paymentCash or cash equivalentPROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED 2019
2019-02-04Boston Scientific Corporation$3,260Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTAPPRAISE ATP2019
2019-02-01Eli Lilly and Company$158Research paymentIn-kind items and servicesA RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF ABEMACICLIB COMBINED WITH STANDARD ADJUVANT ENDOCRINE THERAPY VERSUS STANDARD2019
2019-01-30Abbott Laboratories$44,952Research paymentCash or cash equivalentAMPLATZER Amulet Left Atrial Appendage Occlude Device, Cardiac Arrhythmias and Heart FailureAMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial2019
2019-01-30Abbott Laboratories$2,400Research paymentCash or cash equivalentOptisure Lead Device, Cardiac Arrhythmias and Heart FailureOptisure Lead Post Approval Study2019
2019-01-28Eli Lilly and Company$30,302Research paymentCash or cash equivalentA STUDY OF ABIRATERONE ACETATE PLUS PREDNISONE WITH OR WITHOUT ABEMACICLIB (LY2835219) IN PARTICIPANTS WITH PROSTATE CAN2019
2019-01-23E.R. Squibb & Sons, L.L.C.$4,800Research paymentCash or cash equivalentOPDIVO Biological, OncologyLung cancer molecular profiling and clinical outcomes in US oncology community practices2019
2019-01-22Boston Scientific Corporation$19,737Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTASAP TOO2019
2019-01-22Boston Scientific Corporation$5,548Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTSMART REGISTRY2019
2019-01-22Boston Scientific Corporation$3,890Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTSAVAL PIVOTAL2019
2019-01-22Boston Scientific Corporation$576Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTPINNACLE FLX2019
2019-01-18Celgene Corporation$3,235Research paymentCash or cash equivalentRevlimid Drug, Hematology / OncologyCelgene - Connect MDSAML2019
2019-01-17Boston Scientific Corporation$370Research paymentIn-kind items and servicesCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTSAVAL PIVOTAL2019
2019-01-17Boston Scientific Corporation$6Research paymentIn-kind items and servicesCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTSAVAL PIVOTAL2019
2019-01-16Abbott Laboratories$29,965Research paymentCash or cash equivalentAMPLATZER Amulet Left Atrial Appendage Occlude Device, Cardiac Arrhythmias and Heart FailureAMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial2019

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

Craighead CountyJonesboro city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Jonesboro, AR, county Craighead County, AR, state Arkansas; placed by its city name.

MeasurePlace (city or town)
Jonesboro, AR
County
Craighead County, AR
State
Arkansas
Population B0100380,137113,2493,049,391
Population, 2020 census P178,576111,2313,011,524
Median age B0100233.934.538.5
Under 18 B0100124.0%25.2%23.1%
65 and over B0100114.2%13.9%17.6%
Households B1100131,91344,4371,205,987
Foreign born B050024.6%3.7%5.4%
Median household income B19013$55,424$59,548$60,773
Median family income B19113$72,057$75,703$76,968
Per capita income B19301$33,544$33,774$34,225
Poverty rate B1700122.8%20.1%16.0%
Unemployment rate B230256.3%5.6%4.9%
Civilian labor force B2302538,91255,5351,411,269
Mean commute (minutes) B0801318.019.622.5
Bachelor's degree or higher B1500331.8%29.7%25.7%
Housing units B2500135,00248,8851,394,673
Owner-occupied B2500354.3%60.1%66.4%
Renters B2500345.7%39.9%33.6%
Median home value B25077$223,200$210,400$188,000
Median gross rent B25064$956$958$947
White, not Hispanic B0300263.0%70.8%67.4%
Black B0300222.7%16.6%14.6%
Hispanic or Latino B030027.5%6.3%9.0%
Asian B030021.6%1.2%1.6%
American Indian and Alaska Native B030020.2%0.2%0.3%

Economy now FRED unemployment 3.9% in Sep 2026 (4.2% a year earlier); per capita personal income $61,697 in 2025, up 31% in five years (+5.2% after inflation); Unemployment rate: 3.9% in Sep 2016 to 3.8% in Oct 2026; low 2.9%, high 10.1% the state; Source: FRED, Federal Reserve Bank of St. Louis.

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Jonesboro, AR.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.